Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital [Member]
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2021 $ 50,234 $ 122 $ 428,605 $ (378,493)  
Beginning balance (in shares) at Dec. 31, 2021   12,185,019      
Issuance of ordinary shares, net 6   6    
Issuance of ordinary shares, net (in shares)   38,542      
Share-based compensation expense 1,895   1,895    
Net loss (3,500)     (3,500)  
Ending balance at Mar. 31, 2022 48,635 $ 122 430,506 (381,993)  
Ending balance (in shares) at Mar. 31, 2022   12,223,561      
Beginning balance at Dec. 31, 2021 50,234 $ 122 428,605 (378,493)  
Beginning balance (in shares) at Dec. 31, 2021   12,185,019      
Net loss 44,434        
Ending balance at Dec. 31, 2022 27,999 $ 126 451,150 (422,927) $ (350)
Ending balance (in shares) at Dec. 31, 2022   12,598,641      
Issuance of ordinary shares, net 235 $ 2 233    
Issuance of ordinary shares, net (in shares)   207,192      
Share-based compensation expense 393   393    
Net loss (9,889)     (9,889)  
Unrealized gain on available-for-sale securities 219       219
Ending balance at Mar. 31, 2023 $ 18,957 $ 128 $ 451,776 $ (432,816) $ (131)
Ending balance (in shares) at Mar. 31, 2023   12,805,833